로딩 중…
지수 로딩 중…
WSI Co., Ltd.
299170· KOSDAQ· Health Care· Health Care Equipment & Services
₩1,486-5.41%
2026-06-19
Price Chart
WSI Co., Ltd.-14.60%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 61.69B KRW |
| Revenue | 50.83B KRW |
| Net Income | -3.36B KRW |
| Total Assets | 87.07B KRW |
| Net Assets | 62.61B KRW |
| Employees | 33 |
| Value | |
| P/B | 0.99x |
| P/S | 1.21x |
| FCF Yield | 3.50% |
| Profitability | |
| ROE | -5.36% |
| ROA | -3.86% |
| Op. Margin | -1.20% |
| Revenue Growth | -6.85% |
| Earnings Growth | -109.62% |
| Financial Health | |
| Debt Ratio | 139.07% |
| Total Debt | 21.50B KRW |
| FCF | 2.16B KRW |
| Cash | 6.97B KRW |
| Current Ratio | 2.81x |
| Performance | |
| 1Y Return | -14.60% |
| 1M Return | -25.36% |
| From 52W High | -70.28% |
| 1Y MDD | -64.45% |
| Trading | |
| Volume | 435,124 shares |
| Foreign Own. | 3.43% |
| Per Share | |
| EPS | -112 KRW |
| BPS | 1,443 KRW |
Company Info
CEO 이윤석
Employees 33
Founded 2018
HQ 서울특별시 송파구, KR
Established in 2016, WSI was listed on KOSDAQ in 2020 following its merger with IBKS No.10 Special Purpose Acquisition Company. The company's main business is the distribution of spinal and joint medical devices. In 2024, WSI acquired a 67% stake in pharmaceutical company Introbio Pharma, adding pharmaceutical manufacturing and R&D, with plans to acquire an additional 10% in the first half of 2025. Headquartered in Songpa-gu, Seoul, WSI is also entering the cardiovascular interventional medical device market from 2024 through collaboration with a global cardiac disease medical device company.